Literature DB >> 32749684

Patterns of cancer family history and genetic counseling eligibility among African Americans with breast, prostate, lung, and colorectal cancers: A Detroit Research on Cancer Survivors cohort study.

Kristen S Purrington1,2, Ann G Schwartz1,2, Julie J Ruterbusch1,2, Mark A Manning1,2, Mrudula Nair1,2, Angela S Wenzlaff1,2, Stephanie S Pandolfi1,2, Michael S Simon1,2, Jennifer Beebe-Dimmer1,2.   

Abstract

BACKGROUND: Family history (FH) remains one of the strongest risk factors for many common cancers and is used to determine cancer genetic counseling (CGC) eligibility, but the understanding of familial cancer patterns in African Americans is limited.
METHODS: This study evaluated cancer FH among African Americans with invasive breast cancer, prostate cancer, lung cancer, or colorectal cancer (CRC) in the Detroit Research on Cancer Survivors (ROCS) cohort. Associations between participant cancer type, site-specific FH, and meeting national guidelines for CGC were evaluated via logistic regression. Cancer FH patterns were evaluating via hierarchical clustering.
RESULTS: Among 1500 ROCS participants, 71% reported at least 1 first-degree relative or grandparent with cancer. FHs of breast cancer, CRC, lung cancer, and prostate cancer were most common among participants with the same diagnosis (odds ratio [OR] for breast cancer, 1.14; P < .001; OR for CRC, 1.08; P = .003; OR for lung cancer, 1.09; P = .008; OR for prostate cancer, 1.14; P < .001). Nearly half of the participants (47%) met national CGC guidelines, and 24.4% of these participants met CGC criteria on the basis of their cancer FH alone. FH was particularly important in determining CGC eligibility for participants with prostate cancer versus breast cancer (OR for FH vs personal history alone, 2.91; 95% confidence interval, 1.94-4.35; P < .001). In clustering analyses, breast and prostate cancer FH-defined clusters were common across all participants. Clustering of CRC and breast cancer FHs was also observed.
CONCLUSIONS: ROCS participants reported high rates of cancer FH. The high rate of eligibility for CGC among ROCS participants supports the need for interventions to increase referrals and uptake of CGC among African Americans.
© 2020 American Cancer Society.

Entities:  

Keywords:  familial cancer; hereditary syndromes; racial disparities

Year:  2020        PMID: 32749684      PMCID: PMC8027783          DOI: 10.1002/cncr.33126

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  34 in total

1.  Association between the Lynch syndrome gene MSH2 and breast cancer susceptibility in a Canadian familial cancer registry.

Authors:  Mira Goldberg; Kathleen Bell; Melyssa Aronson; Kara Semotiuk; Greg Pond; Steven Gallinger; Kevin Zbuk
Journal:  J Med Genet       Date:  2017-08-04       Impact factor: 6.318

Review 2.  Genetic architecture of colorectal cancer.

Authors:  Ulrike Peters; Stephanie Bien; Niha Zubair
Journal:  Gut       Date:  2015-07-17       Impact factor: 23.059

3.  Lynch syndrome caused by MLH1 mutations is associated with an increased risk of breast cancer: a cohort study.

Authors:  Elaine F Harkness; Emma Barrow; Katy Newton; Kate Green; Tara Clancy; Fiona Lalloo; James Hill; D Gareth Evans
Journal:  J Med Genet       Date:  2015-06-22       Impact factor: 6.318

Review 4.  A systematic review and meta-analysis of familial colorectal cancer risk.

Authors:  L E Johns; R S Houlston
Journal:  Am J Gastroenterol       Date:  2001-10       Impact factor: 10.864

5.  Prostate Cancer, Version 2.2019, NCCN Clinical Practice Guidelines in Oncology.

Authors:  James L Mohler; Emmanuel S Antonarakis; Andrew J Armstrong; Anthony V D'Amico; Brian J Davis; Tanya Dorff; James A Eastham; Charles A Enke; Thomas A Farrington; Celestia S Higano; Eric Mark Horwitz; Michael Hurwitz; Joseph E Ippolito; Christopher J Kane; Michael R Kuettel; Joshua M Lang; Jesse McKenney; George Netto; David F Penson; Elizabeth R Plimack; Julio M Pow-Sang; Thomas J Pugh; Sylvia Richey; Mack Roach; Stan Rosenfeld; Edward Schaeffer; Ahmad Shabsigh; Eric J Small; Daniel E Spratt; Sandy Srinivas; Jonathan Tward; Dorothy A Shead; Deborah A Freedman-Cass
Journal:  J Natl Compr Canc Netw       Date:  2019-05-01       Impact factor: 11.908

6.  Familial clustering of breast and prostate cancer and risk of postmenopausal breast cancer in the Women's Health Initiative Study.

Authors:  Jennifer L Beebe-Dimmer; Cecilia Yee; Michele L Cote; Nancie Petrucelli; Nynikka Palmer; Cathryn Bock; Dorothy Lane; Ilir Agalliu; Marcia L Stefanick; Michael S Simon
Journal:  Cancer       Date:  2015-03-09       Impact factor: 6.860

Review 7.  Common Genetic Variation and Breast Cancer Risk-Past, Present, and Future.

Authors:  Jenna Lilyquist; Kathryn J Ruddy; Celine M Vachon; Fergus J Couch
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2018-01-30       Impact factor: 4.254

8.  African American women's limited knowledge and experiences with genetic counseling for hereditary breast cancer.

Authors:  Vanessa B Sheppard; Kristi D Graves; Juleen Christopher; Alejandra Hurtado-de-Mendoza; Costellia Talley; Karen Patricia Williams
Journal:  J Genet Couns       Date:  2013-11-05       Impact factor: 2.537

Review 9.  A Decade of GWAS Results in Lung Cancer.

Authors:  Yohan Bossé; Christopher I Amos
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2017-06-14       Impact factor: 4.254

Review 10.  Awareness, knowledge, perceptions, and attitudes towards genetic testing for cancer risk among ethnic minority groups: a systematic review.

Authors:  Katie E J Hann; Madeleine Freeman; Lindsay Fraser; Jo Waller; Saskia C Sanderson; Belinda Rahman; Lucy Side; Sue Gessler; Anne Lanceley
Journal:  BMC Public Health       Date:  2017-05-25       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.